Amgen Inc. buy The Goldman Sachs Group, Inc.
Start price
07.02.24
/
50%
€289.60
Target price
07.02.25
€324.87
Performance (%)
-12.14%
Price
26.04.24
€252.35
Summary
This prediction is currently active. The prediction for Amgen Inc. disappoints with a performance of -12.14%. A total of €2.09 was paid as dividends for this prediction. This prediction currently runs until 07.02.25. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | -0.040% | -0.040% |
| iShares Core DAX® | 2.594% | -1.158% |
| iShares Nasdaq 100 | 3.553% | -1.727% |
| iShares Nikkei 225® | 0.687% | -8.354% |
| iShares S&P 500 | 2.209% | -0.942% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $313.00 to $350.00. They now have a "buy" rating on the stock.
Ratings data for AMGN provided by MarketBeat